PAX8 and neuroendocrine neoplasm: Overall, PAX8 is expressed in primary and metastatic pancreatic well-differentiated neuroendocrine tumors, enabling reliable differentiation between pancreatic and ileal and pulmonary well-differentiated neuroendocrine tumors using immunostaining methods.